ProQR Therapeutics

PRQRNasdaq Netherlands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$262.486 M

$1.86 +1.64%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

105,361,064

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#245Pyxis OncologyPYXS$266.1M
#246Yarrow BioscienceYARW$263.3M
#247ProQR TherapeuticsPRQR$262.5M
#248MacrogenicsMGNX$262.4M
#249Camp4 TherapeuticsCAMP$261.7M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of ProQR Therapeutics, worth $354.0K. Grants and option exercises are excluded.

Boer Daniel Anton DeChief Executive Officer$354.0K
200,000 shares at $1.77 on 31 Jul 2026 · filed 3 Aug 2026

What if ProQR Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$214,524.78

Per share 115,336× higher

Bitcoin $1.72T

$12,186.69

Per share 6,552× higher

Nvidia $5.48T

$38,830.79

Per share 20,877× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for ProQR Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.